Ra Capital Management, L.P. Graphite Bio, Inc. Transaction History

Ra Capital Management, L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$2.14 - $5.23 $5.77 Million - $14.1 Million	-2,698,369 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.5 - $30.73 $49.9 Million - $82.9 Million	2,698,369 New	2,698,369 $82.9 Million

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.